WeChat-Based Intervention for Glycemic Control in Patients With Type 2 Diabetes Mellitus: Multicenter Randomized Controlled Trial.

ABSTRACT:

Background

China's diabetes epidemic faces critical gaps in glycemic control, with only 50.1% of treated patients achieving hemoglobin A1C (HbA1c) targets in 2021. Conventional interventions struggle with scalability in primary care, particularly for vulnerable populations.

Objective

This study aimed to evaluate the use of a WeChat-based health education tool (the WeWalk mini program, the Bayu Health public account, and a WeChat group) for improving glycemic control in community-dwelling patients with type 2 diabetes mellitus.

Methods

This multicenter randomized controlled trial enrolled 600 adults with type 2 diabetes from 3 communities in Chongqing, randomly allocating participants 1:1 to either a 12-week WeChat-based intervention (n=300, 50%) or a control group (n=

SUBMITTER: Zheng C 

PROVIDER: S-EPMC12923094 | biostudies-literature | 2026 Feb

REPOSITORIES: biostudies-literature